Status:
COMPLETED
The Effect of Different Drugs in the Prevention of Tooth Sensitivity Caused by Tooth Bleaching Treatment.
Lead Sponsor:
Universidade Estadual de Ponta Grossa
Collaborating Sponsors:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Universidade Estadual do Oeste do Paraná
Conditions:
Hydrogen Peroxide Allergy
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Background: The administration of the intra-oral drugs was not capable of reducing this side effect, maybe the use of two analgesics may to present better analgesic effect to avoid the bleaching-induc...
Detailed Description
Trial design, settings and locations of data collection This was a randomized, parallel, placebo-controlled, triple-mask clinical trial, in which the patient, operator and evaluator were masked to the...
Eligibility Criteria
Inclusion
- Patients were at least 18 years old.
- Patients had good general and oral health, and did not report any type of tooth sensitivity (TS).
- The participants were required to have six caries-free maxillary anterior teeth and without restorations, absence of periodontal disease and must reviewed and signed the informed consent form.
- The central incisors should be shade A2 or darker as judged by comparison with a value-oriented shade guide (Vita Classical, Vita Zahnfabrik, Bad Säckingen, Germany).
Exclusion
- Participants with anterior restorations or dental prosthesis, with orthodontics apparatus, with severe internal tooth discoloration (tetracycline stains, fluorosis, pulpless teeth) were not included in the study.
- Pregnant/lactating women, participants with any other pathology that could cause sensitivity (such as recession, dentine exposure, presence of visible cracks in teeth), taking anti-inflammatory and/or analgesic drugs, smokers, bruxists or participants that had undergone tooth-whitening procedures were also excluded.
- Patients that reported some earlier or present health problems in stomach, heart, kidney and liver, participants reporting continuous use of anti-inflammatory and/or analgesic drugs were excluded.
- Diabetics, hypertensive or patients with known allergy to acetaminophen and lactose.
Key Trial Info
Start Date :
November 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT03343392
Start Date
November 5 2017
End Date
December 1 2018
Last Update
November 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eloisa Andrade de Paula
Santos, São Paulo, Brazil, 11045551